SCHEMBL30745367

SCHEMBL30745367

CC(C)(C)OC(=O)N1CCCC1c1cccc(COc2ccc(Cl)cc2Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.49
▸ MAPT P10636 4/20 0.48
▸ LMNA P02545 3/20 0.48
▸ TSHR P16473 3/20 0.48
▸ HTT P42858 3/20 0.48
▸ NPSR1 Q6W5P4 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ MRGPRX4 Q96LA9 7/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ MDM2 Q00987 1/20 0.43
▸ GPR55 Q9Y2T6 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ USP2 O75604 1/20 0.43
▸ ADAM17 P78536 1/20 0.42
▸ KCNH2 Q12809 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30745369 0.84 PDE4B (0.50) ALDH1A1MAPTLMNATSHRHTT
SCHEMBL24793022 0.84 PDE4B (0.50) ALDH1A1MAPTLMNATSHRHTT
SCHEMBL30745421 0.84 PDE4B (0.50) ALDH1A1MAPTLMNATSHRHTT
SCHEMBL24793021 0.84 PDE4B (0.50) ALDH1A1MAPTLMNATSHRHTT
SCHEMBL24792598 0.84 PDE4B (0.50) ALDH1A1MAPTLMNATSHRHTT
SCHEMBL30745366 0.84 MRGPRX4 (0.49) ALDH1A1MAPTLMNATSHRHTT
SCHEMBL30745393 0.83 MRGPRX4 (0.47) ALDH1A1MAPTLMNATSHRHTT
SCHEMBL30745404 0.82 MRGPRX4 (0.49) ALDH1A1MAPTLMNATSHRHTT
SCHEMBL30745379 0.81 MRGPRX4 (0.47) ALDH1A1MAPTLMNATSHRHTT
SCHEMBL8223030 0.80 RIPK1 (0.51) ALDH1A1MAPTLMNATSHRNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117545748-A Benzimidazolyl GLP-1GPCR receptor agonists, pharmaceutical compositions comprising the same, and methods of use thereof 卡莫特医疗有限公司 2024-02-09 — — CN disclosed
Send feedback